Eden Medical Center stands at the forefront of treating stroke and neurovascular disorders.

Our Primary Stroke Care Center provides advanced neurovascular and neurocritical care and rehabilitation from highly trained stroke specialists, increasing your chances of a full recovery.

Our stroke center was awarded the American Heart Association/American Stroke Association Get with The Guidelines Gold Plus Achievement Award, which ensures you receive treatment according to nationally accepted standards and recommendations. The data below highlights our excellent outcomes, including thrombolytic treatment administration and stroke education statistics.

Ischemic Stroke Patients Treated with Tenecteplase

For 2023 we provided thrombolytic therapy in under 30 minutes to all our eligible patients! That is 100% goal accomplishment!

What are we measuring?
The percentage of patients with ischemic strokes (when blood supply to the brain is blocked) arriving at the emergency room who can receive Tenecteplase (clot dissolving medication) to potentially reverse the effects of an acute stroke.

Why is this important?
Tenecteplase is a "clot-busting" medication that can potentially reverse the symptoms and effects of ischemic strokes. It must be given within the first 4.5 hours of “Last known well.” Because of this narrow window of time and the unavailability of acute stroke management services, the nationwide average for this treatment is less than 5%.

Neurointerventional capabilities:
We offer a full range of advanced Neurointerventional capabilities and other services including:

• Advanced imaging technology to diagnose a stroke and determine the best treatment approach quickly and accurately.

• Comprehensive surgical brain care including the latest interventional neuroradiology treatments, including stent retrievers that grasp blood clots and suction them out while a stroke is in progress.

At Eden we pride ourselves on offering these services to all eligible ischemic stroke patients. Our physicians will often take patients for immediate lifesaving intervention that may not be treated for at other facilities. For 2022-2023, our team took 100% of eligible patients to the Neuro-Interventional Suite for treatment.

When a stroke is happening due to a blood vessel being blocked, the goal of emergent treatment is to restore blood flow to the brain. A Neuro-Interventional specialist performs a procedure called a thrombectomy to remove the clot and restore blood flow to the brain. In 2023, Eden restored blood flow for patients presenting with large clotting strokes at a higher rate than other hospitals.

• Eden: 89%

• California Hospitals Benchmark: 87.1%

• Source: Quintiles Stroke Registry, 2023

Performance Measures

Eden Medical Center is a certified Primary Stroke Center receiving certification from The Joint Commission. The Joint Commission's stroke (STK) measures were developed in collaboration with the American Heart Association (AHA)/American Stroke Association (ASA)/Brain Attack Coalition (BAC) for use by Disease-Specific Care (DSC)-certified primary stroke centers.

Note: A higher percentage is better.

Here at Eden, we provide high quality Stroke care for our community.

If you have any questions and/or concerns, please feel free to contact us at our office line: (510) 537-1234.

You can also email our Neuroscience Director at BryanJason.Rivera@sutterhealth.org